How do you pay?

How to pay the least

Ask for the cash price

Oxervate

Oxervate is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Oxervate’s cash price, and one or two other pharmacies too.
  2. Oxervate’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameOxervate
Authorized genericcenegermin-bkbj
Regular genericcenegermin-bkbj
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Oxervate?
The original
–
–

Brand nameThe maker’s card

Dompé CONNECT to Care Copay Program

Savings card from Dompé farmaceutici

No insuranceNeeds insuranceNo cash price listed.
Insurance $0 a prescription

Sign up on oxervatehcp.com 

In the maker’s words

“patients pay $0 for OXERVATE…”

From the maker’s offer on oxervatehcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Oxervate itself, from the same company, sold without the brand name, and usually for less. For now Oxervate is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Oxervate is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

OXERVATE is a recombinant human nerve growth factor indicated for the treatment of neurotrophic keratitis.

Source: the FDA label for Oxervate (Dompé farmaceutici S.p.A.), December 31, 2024. Full label on DailyMed 

Good to know